A randomized prospective study comparing low-dose 0KT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients
Open Access
- 1 May 1998
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 11 (3) , 231-236
- https://doi.org/10.1111/j.1432-2277.1998.tb00807.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Reduced dose OKT3 prophylaxis in sensitised kidney recipientsTransplant International, 1996
- HALF DOSE OF OKT3 IS EFFICIENT IN TREATMENT OF STEROID-RESISTANT RENAL ALLOGRAFT REJECTIONTransplantation, 1996
- RANDOMIZED CLINICAL TRIAL OF ANTITHYMOCYTE GLOBULIN INDUCTION IN RENAL TRANSPLANTATION COMPARING A FIXED DAILY DOSE WITH DOSE ADJUSTMENT ACCORDING TO T CELL MONITORINGTransplantation, 1995
- A RANDOMIZED PROSPECTIVE TRIAL OF PROPHYLACTIC IMMUNOSUPPRESSION WITH ATG-FRESENIUS VERSUS OKT3 AFTER RENAL TRANSPLANTATIONTransplantation, 1995
- Administration of ATG according to the absolute T lymphocyte count during therapy for steroid-resistant rejectionTransplant International, 1993
- SEQUENTIAL THERAPY—A PROSPECTIVE RANDOMIZED TRIAL OF MALG VERSUS OKT3 FOR PROPHYLACTIC IMMUNOSUPPRESSION IN CADAVER RENAL ALLOGRAFT RECIPIENTSTransplantation, 1992
- PHARMACOKINETIC STUDY OF ORTHOCLONE OKT3 SERUM LEVELS DURING TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTIONTransplantation, 1988
- OKT3 MONOCLONAL ANTIBODY PLASMA LEVELS DURING THERAPY AND THE SUBSEQUENT DEVELOPMENT OF HOST ANTIBODIES TO OKT3Transplantation, 1986
- TREATMENT OF ACUTE REJECTION OF CADAVERIC RENAL ALLOGRAFTS WITH RABBIT ANTITHYMOCYTE GLOBULINTransplantation, 1982
- TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT3 MONOCLONAL ANTIBODYTransplantation, 1981